Cargando…
A Digital Solution to Improve Safety of Valproate Prescribing in Mental Health
AIMS: Valproate is a licensed medicine prescribed within mental health settings for bipolar disorder. It is a known teratogen, affecting approximately 20,000 people and costing the NHS £181 billion. This was a multidisciplinary project involving Surrey Heartlands Medicines Safety Team and Surrey and...
Autores principales: | Mohamed, Ashma, Marshall, Alison, Smith, Nikki, Smith, Anna, Sowa, Barbara, England, Sue, Long, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345488/ http://dx.doi.org/10.1192/bjo.2023.303 |
Ejemplares similares
-
Improving the Quality of Valproate Prescribing in Adult Mental Health Services - POMH Topic 20b - Enhanced Community Rehabilitation Service (ECRS), Bognor Regis, West Sussex
por: Hussain, Labib, et al.
Publicado: (2023) -
A quality improvement (QI) project to ensure females on valproate in a CMHT outpatient clinic, eput are registered on the valproate pregnancy prevention programme
por: Emmanuel, Adebayo, et al.
Publicado: (2021) -
Antipsychotic Cardiometabolic Monitoring: Systemic Gaps and Hidden Groups
por: Ansari, Tanya, et al.
Publicado: (2022) -
Quality improvement in remote prescribing
por: Bader, Mohamed, et al.
Publicado: (2021) -
Prescribing and monitoring high dose and combined antipsychotics in community mental health team
por: Banerjee, Dipanjan, et al.
Publicado: (2021)